FDA clears EnSite velocity Cardiac Mapping System
The FDA has cleared the way for St Jude Medical Inc to launch its new EnSite velocity Cardiac Mapping System. The new system has been designed to help doctors diagnose and guide therapy to treat abnormal heart rhythms. The system, used in minimally invasive electrophysiology procedures, uses catheters with electrodes inserted into a cardiac chamber. The electrodes then relay electrical information from the heart in a 3-D anatomical model.
- Biosense Webster Gets FDA Clearances For The CartoXPress(TM) Software Module And Lasso(R) NAV Catheter For Its Carto(R) XP System
- FDA clears Cardica’s PAS-Port for commercial launch
- Biosense Webster Gets FDA Clearance for its CARTO® 3 System
- Philips introduces advancements in Xcelera system
